RCT | Surgery reduced major adverse limb events vs. endovascular therapy in patients with chronic limb-threatening ischemia.

Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia – New England Journal of Medicine (link to abstract – $ for full-text)

News Release: Bypass surgery favorable for initial treatment of chronic limb-threatening ischemia – National Institutes of Health

Commentary on Twitter

In a randomized trial of patients with limb ischemia, those assigned to bypass surgery as compared with endovascular therapy as an initial strategy had fewer adverse limb events or all-cause death at a median of 2.7 years. #AHA22 https://t.co/GePo1ss1ar pic.twitter.com/bmH56dMkHP

— NEJM (@NEJM) November 7, 2022